Table 1.
Endurance performances of placebo and treatment arms.
| Placebo | Treatment | p-Value * | |
|---|---|---|---|
| 3 km test velocity (km/h) | 13.31 ± 0.75 | 13.44 ± 0.71 | 0.509 |
| 15 km test velocity (km/h) | 15.59 ± 1.46 | 15.59 ± 1.45 | 0.992 |
| Mean heart rate during 3 km (bpm) | 145.96 ± 10.1 | 146.64 ± 11.96 | 0.829 |
| Mean heart rate during 15 km (bpm) | 171.38 ± 8.85 | 171.23 ± 9.18 | 0.951 |
| Maximal heart rate during 15 km (bpm) | 179.58 ± 9.70 | 179.46 ± 8.56 | 0.964 |
| Rating of perceived exertion | 7.15 ± 1.74 | 6.96 ± 1.66 | 0.685 |
| Baseline lactate (mmol/L) | 1.35 ± 0.21 | 1.32 ± 0.24 | 0.629 |
| Post-running lactate (mmol/L) | 5.14 ± 1.95 | 4.64 ± 1.44 | 0.298 |
| Post–pre test delta weight (kg) | −1.33 ± 0.43 | −1.28 ± 0.40 | 0.690 |
| GI symptoms (n) | 6 (23.1) | 4 (15.4) | 0.481 |
bpm = beats per minute; * p-value refers to the comparison between the two arms. Results were shown as mean ± SD or frequency and percentage (%). GI = gastronitestinal.